Хайлтын үр дүнгүүд - Han-Zhang, Han
- 38-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report -н Zhu, Baorang, Liu, Ying, Li, Jing, Diao, Liyan, Shao, Lin, Han‐Zhang, Han, Zhang, Lu, Kang, Qiaolin, Yang, Wuwei
Хэвлэсэн 2019текст -
5
Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis -н He, Yiping, Ma, Xiaoji, Chen, Ke, Liu, Fangqi, Cai, Sanjun, Han-Zhang, Han, Hou, Ting, Xiang, Jianxing, Peng, Junjie
Хэвлэсэн 2020текст -
6
-
7
-
8
The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients -н Lin, Quan, Zhang, Haoran, Ding, Huaxin, Qian, Jun, Lizaso, Analyn, Lin, Jing, Han-Zhang, Han, Xiang, Jianxing, Li, Yuping, Zhu, Hong
Хэвлэсэн 2019текст -
9
Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer -н Mo, Shaobo, Ma, Xiaoji, Li, Yaqi, Zhang, Long, Hou, Ting, Han-Zhang, Han, Qian, Juanjuan, Cai, Sanjun, Huang, Dan, Peng, Junjie
Хэвлэсэн 2020текст -
10
Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma -н Li, Yan, Tan, Yan, Hu, Song, Xie, Jun, Yan, Zhantao, Zhang, Xian, Zong, Yun, Han-Zhang, Han, Li, Qing, Li, Chong
Хэвлэсэн 2021текст -
11
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose... -н Ji, Linong, Jiang, Hongwei, An, Pei, Deng, Huan, Liu, Meng, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei
Хэвлэсэн 2021текст -
12
Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma -н Zhou, Zhen, Zhu, Lei, Niu, Xiaomin, Shen, Shengping, Zhao, Yi, Zhang, Jie, Ye, Junyi, Han‐Zhang, Han, Liu, Junjun, Liu, Chenglin, Lu, Shun
Хэвлэсэн 2019текст -
13
Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treat... -н Xia, Shu, Ye, Junyi, Chen, Yu, Lizaso, Analyn, Huang, Le, Shi, Lei, Su, Jing, Han-Zhang, Han, Chuai, Shannon, Li, Lingling, Chen, Yuan
Хэвлэсэн 2019текст -
14
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor -н He, Junjun, Ouyang, Wei, Zhao, Wugan, Shao, Lin, Li, Bing, Liu, Bihao, Wang, Dejuan, Han-Zhang, Han, Zhang, Zhou, Shao, Liang, Li, Wencai
Хэвлэсэн 2021текст -
15
Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients -н Xiong, Liwen, Lou, Yuqing, Bai, Hao, Li, Rong, Xia, Jinjing, Fang, Wentao, Zhang, Jie, Han-Zhang, Han, Lizaso, Analyn, Li, Bing, Gu, Aiqin, Han, Baohui
Хэвлэсэн 2019текст -
16
Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring -н Qi, Fei, Cao, Zheng, Chen, Bo, Chai, Yue, Lin, Jing, Ye, Junyi, Wei, Yuce, Liu, Hao, Han-Zhang, Han, Mao, Xinru, Feng, Xiaoli, Dong, Mei
Хэвлэсэн 2021текст -
17
-
18
Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer -н Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Хэвлэсэн 2021текст -
19
Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics -н Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Хэвлэсэн 2021текст -
20
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes -н Jiang, Hongwei, Pang, Shuguang, Zhang, Yawei, Yu, Ting, Liu, Meng, Deng, Huan, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei, Yang, Wenying
Хэвлэсэн 2022текст